2026-08-29T09:24:53Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/52312025-05-13T11:15:56Zcom_20.500.12105_19604com_20.500.12105_2051col_20.500.12105_19605

00925njm 22002777a 4500 dc Garcia-Ruiz, Jose M author Fernandez-Jimenez, Rodrigo author Garcia-Alvarez, Ana author Pizarro, Gonzalo author Galan-Arriola, Carlos author Fernandez-Friera, Leticia author Mateos, Alonso author Nuno-Ayala, Mario author Aguero, Jaume author Sanchez-Gonzalez, Javier author Garcia-Prieto, Jaime author Lopez-Melgar, Beatriz author Martinez-Tenorio, Pedro author Lopez-Martin, Gonzalo J. author Macias, Angel author Perez-Asenjo, Braulio author Cabrera, José Ángel author Fernandez-Ortiz, Antonio author Fuster, Valentin author Ibáñez, Borja author 2016 BACKGROUND Pre-reperfusion administration of intravenous (IV) metoprolol reduces infarct size in ST-segment elevation myocardial infarction (STEMI). OBJECTIVES This study sought to determine how this cardioprotective effect is influenced by the timing of metoprolol therapy having either a long or short metoprolol bolus-to-reperfusion interval. METHODS We performed a post hoc analysis of the METOCARD-CNIC (effect of METOprolol of CARDioproteCtioN during an acute myocardial InfarCtion) trial, which randomized anterior STEMI patients to IV metoprolol or control before mechanical reperfusion. Treated patients were divided into short-and long-interval groups, split by the median time from 15 mg metoprolol bolus to reperfusion. We also performed a controlled validation study in 51 pigs subjected to 45 min ischemia/reperfusion. Pigs were allocated to IV metoprolol with a long (-25 min) or short (-5 min) pre-perfusion interval, IV metoprolol post-reperfusion (+60 min), or IV vehicle. Cardiac magnetic resonance (CMR) was performed in the acute and chronic phases in both clinical and experimental settings. RESULTS For 218 patients (105 receiving IV metoprolol), the median time from 15 mg metoprolol bolus to reperfusion was 53 min. Compared with patients in the short-interval group, those with longer metoprolol exposure had smaller infarcts (22.9 g vs. 28.1 g; p = 0.06) and higher left ventricular ejection fraction (LVEF) (48.3\% vs. 43.9\%; p = 0.019) on day 5 CMR. These differences occurred despite total ischemic time being significantly longer in the long-interval group (214 min vs. 160 min; p < 0.001). There was no between-group difference in the time from symptom onset to metoprolol bolus. In the animal study, the long-interval group (IV metoprolol 25 min before reperfusion) had the smallest infarcts (day 7 CMR) and highest long-term LVEF (day 45 CMR). CONCLUSIONS In anterior STEMI patients undergoing primary angioplasty, the sooner IV metoprolol is administered in the course of infarction, the smaller the infarct and the higher the LVEF. These hypothesis-generating clinical data are supported by a dedicated experimental large animal study. (C) 2016 by the American College of Cardiology Foundation. J Am Coll Cardiol. 2016; 67(18):2093-2104 10.1016/j.jacc.2016.02.050 1558-3597 0735-1097 Journal of the American College of Cardiology 27052688 http://hdl.handle.net/20.500.12105/5231 ACUTE MYOCARDIAL-INFARCTION ST-SEGMENT-ELEVATION PERCUTANEOUS CORONARY INTERVENTION 2013 ACCF/AHA GUIDELINE ASSOCIATION TASK-FORCE METOCARD-CNIC TRIAL CLINICAL-TRIAL BETA-BLOCKERS ISCHEMIA/REPERFUSION CARDIOPROTECTION Impact of the Timing of Metoprolol Administration During STEMI on Infarct Size and Ventricular Function